Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy

Spinal cord atrophy as a measure of severity of myelopathy in adrenoleukodystrophy

(2020) Stephanie I. W. Stadt et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Disease progression in women with X-linked adrenoleukodystrophy is slow

(2019) Irene C. Huffnagel et al.   Orphanet Journal of Rare Diseases

Neurofilament light chain as a biomarker in neurological disorders

(2019) Lorenzo Gaetani et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Blood neurofilament light as a potential endpoint in Phase 2 studies in MS

(2019) Maria Pia Sormani et al.   Annals of Clinical and Translational Neurology

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

(2019) Claire Bridel et al.   JAMA Neurology

Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD

(2019) Mitsuru Watanabe et al.   NEUROLOGY

Longitudinal diffusion MRI as surrogate outcome measure for myelopathy in adrenoleukodystrophy

(2019) Irene C. Huffnagel et al.   NEUROLOGY

Serum neurofilament light chain is increased in hereditary spastic paraplegias

(2018) Carlo Wilke et al.   Annals of Clinical and Translational Neurology

The natural history of adrenal insufficiency in X-linked adrenoleukodystrophy: an international collaboration

(2018) Irene C Huffnagel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness

(2018) Irene C Huffnagel et al.   BRAIN

Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review

(2017) Eric Peter Thelin et al.   Frontiers in Neurology

Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy:in vivoassessment of structural changes

(2016) Antonella Castellano et al.   BRAIN

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

(2016) Jens Kuhle et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study

(2016) Marcus D’Souza et al.   Multiple Sclerosis Journal

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Adrenoleukodystrophy – neuroendocrine pathogenesis and redefinition of natural history

(2016) Stephan Kemp et al.   Nature Reviews Endocrinology

Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study

(2016) Marcus D’Souza et al.   Multiple Sclerosis Journal

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

(2016) Magnus Gisslén et al.   EBioMedicine

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

(2015) C.-H. Lu et al.   NEUROLOGY

X-linked adrenoleukodystrophy in women: a cross-sectional cohort study

(2014) Marc Engelen et al.   BRAIN

Severity score system for progressive myelopathy: development and validation of a new clinical scale

(2012) R.M. Castilhos et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management

(2012) Marc Engelen et al.   Orphanet Journal of Rare Diseases

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

(2010) David M Rissin et al.   NATURE BIOTECHNOLOGY